Financial statements Expharm
Balance sheet of Expharm
Company age:
Age:
8 y. 8 m. 17 d.
Share capital:
Share capital:
100 000 PLN
Balance sheet data of EXPHARM
|
Year
|
2018
|
2019
|
|---|---|---|
| Total assets | 1 516 351,80 | 1 377 043,52 |
| A. Fixed assets | 46 310,27 | 42 584,61 |
| B. Current assets | 1 470 041,53 | 1 334 458,91 |
| C. Share capital contributions (basic funds) | 0,00 | - |
| D. Own shares (stocks) | 0,00 | - |
| Total liabilities | 1 516 351,80 | 1 377 043,52 |
| A. Equity | 644 607,27 | 753 471,38 |
| B. Liabilities and provisions for liabilities | 871 744,53 | 623 572,14 |
| I. Long-term liabilities | 400 566,00 | 367 359,49 |
| II. Short-term liabilities | 166 062,18 | 198 801,35 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.